
浏览全部资源
扫码关注微信
纸质出版:2015
移动端阅览
万敏,唐小婷,张巧,李海宁,周雪梅,吴颖,王长征,马千里.哮喘-慢阻肺重叠综合征患者240例临床特征分析[J].陆军军医大学学报(原第三军医大学学报),2015,37(21):2181-2185.
Wan Min,Tang Xiaoting,Zhang Qiao,Li Haining,Zhou Xuemei,Wu Ying,Wang Changzheng,Ma Qianli.Clinical characteristics of asthma and COPD overlap syndrome: report of 240 cases[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(21):2181-2185.
万敏,唐小婷,张巧,李海宁,周雪梅,吴颖,王长征,马千里.哮喘-慢阻肺重叠综合征患者240例临床特征分析[J].陆军军医大学学报(原第三军医大学学报),2015,37(21):2181-2185. DOI:
Wan Min,Tang Xiaoting,Zhang Qiao,Li Haining,Zhou Xuemei,Wu Ying,Wang Changzheng,Ma Qianli.Clinical characteristics of asthma and COPD overlap syndrome: report of 240 cases[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(21):2181-2185. DOI:
目的 探讨哮喘-慢阻肺重叠综合征患者的临床特征。 方法 采用基于医疗信息数据库的回顾性队列研究方法,调取接受治疗随访1年以上,固定气流受限患者信息,按照哮喘、慢阻肺,以及新版2014年哮喘-慢阻肺重叠综合征(asthma and chronic obstructive pulmonary disease overlap syndrome,ACOS)联合指南的标准形成三组患者队列,统计队列中ACOS患者的比例、年龄分布;分析比较患者末次随访的气道炎症细胞、肺功能及年化FEV1下降率等临床特征。 结果 240例初诊特征符合研究标准的患者被纳入分析,按新指南标准分组发现ACOS患者比例为29.17%,以40岁以上年龄患者为主(88.57%),男性患者(61.40%)略多于女性患者,78.58%的患者支气管舒张后第1秒用力肺活量占预计值的比例(postFEV1%pre)在50%以上,其性别组成、中位年龄、肺功能、气道嗜酸性粒细胞炎症患者比例与哮喘患者和慢阻肺患者比较,差异有统计学意义(P0.05),具体数值介于哮喘患者和慢阻肺患者之间。未来风险评估提示虽然ACOS患者年化FEV1下降率与哮喘、慢阻肺患者差异无统计学意义(P0.05),但下降的绝对值最大;而且中、重度年化急性加重的发生率也与慢阻肺患者相似,显著高于哮喘患者(P0.01)。 结论 ACOS患者的临床特征介于哮喘、慢阻肺之间,而其未来风险更接近于慢阻肺。
Objective To investigate the clinical characteristics of asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS). Methods A retrospective cohort of epidemiological cohort study based on our medical information database was performed on the data from those patients with airflow obstruction who were under treatment and followed up for more than 1 year. According to the diagnostic standard of COPD
asthma and ACOS
they were grouped into 3 patient cohorts. The clinical characteristics of ACOS patient cohort were analyzed
including the proportion of patients
age composition
airway inflammation type and lung function at the nearest visit
and the annual decline rate of forced expiratory volume in 1 second (FEV1). Results Two hundreds and forty cases were enrolled in this study who met qualifying criteria for the study. ACOS patients was identified covering 29.17%
with more male (61.4%) than female
in which 88.57% were at an age over 40
and 78.58% had postFEV1%pre 50%. There were significant differences in gender composition
median age
lung function and patients proportion of eosinophil inflammation in the airway in the ACOS cohort compared with the COPD cohort and asthma cohort (P0.05)
and these values were between those of the other 2 cohorts. Especially
the results of disease future risk assessment showed though the annual decline rate of FEV1 had no significant difference among ACOS cohort
COPD cohort and asthma cohort (P0.05)
and the annual decline absolute value of FEV1 was maximum in ACOS cohort. Moreover
the incidence of moderate and severe acute exacerbation of ACOS patients were similar to those of COPD patients
significantly higher than that of asthma patients (P0.01). Conclusion The clinical characteristics of ACOS patients are between those of asthma and COPD
and the disease future risk assessment are closer to COPD patients.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621